A Heart-to-Heart For Researchers

A Heart-to-Heart for Researchers

The second Cardiovascular Research Symposium drew approximately 80 people including researchers, sub-specialty physicians, quality and operational staff, and others from across Kaiser Permanente’s Northern California region. It was convened at the Division of Research (DOR) in Oakland by Alan S. Go, MD, DOR’s associate director of Cardiovascular and Metabolic Conditions Research.
Read More
Eight Weeks Or Twelve? Kaiser Permanente Study Shows Shorter Hepatitis C Regimen Effective In Black Patients

Eight Weeks or Twelve? Kaiser Permanente Study Shows Shorter Hepatitis C Regimen Effective in Black Patients

A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.
Read More